Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

The "Shark Tank" investor and Cost Plus Drugs cofounder Dr. Alex Oshmyansky participated in a White House health care ...

In response, Cost Plus has started a compounding pharmacy to make common generics and soon hopes to have a sort of “private reserve” of 70 to 80 products that it can make on short notice if they go ...

Penn Medicine is partnering with billionaire investor Mark Cuban to streamline the availability of generic prescription drugs for its network of pharmacy locations. The nonprofit health system’s new ...

"But beyond that," Mr. Cuban said, "Not much :)." With its model of selling medicines at cost plus a 15% markup and $10 for shipping and pharmacy labor, several large pharmaceutical companies ...

With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking bold steps to ensure transparency and affordability within the pharmacy benefits arena.

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

Cost Plus Drugs occasionally increases or decreases ... it has halved that to $350,000. In "pharmacy, we've got big targets on our back," Dr. Frodin said. "We're a big spender of health system ...

then charging patients only for the original cost to the company plus 15% and any pharmacy fees. When patients sign up for Cost Plus Drugs, Truepill sends the medications. Truepill had issues ...

With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking bold steps to ensure transparency and affordability within the pharmacy benefits arena. PharmPix - ...